IME 14.1% 36.5¢ imexhs limited

Updated Figures, page-38

  1. 10,010 Posts.
    lightbulb Created with Sketch. 103
    The funny thing is none of us here invested in IME for the FDA approval. It really wasn't even a factor.

    We invested in IME because of its current strong revenues and growth within South America and Asia/Pacific. It was and is still cheap in relation to this alone.

    But interestingly FDA approval for RHT has added around $33m to RHTs MC alone. When this comes for IME I expect we'll move well over 10c quite easily.
 
watchlist Created with Sketch. Add IME (ASX) to my watchlist
(20min delay)
Last
36.5¢
Change
0.045(14.1%)
Mkt cap ! $21.89M
Open High Low Value Volume
36.5¢ 36.5¢ 36.5¢ $7.3K 20K

Buyers (Bids)

No. Vol. Price($)
1 1484 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 17167 1
View Market Depth
Last trade - 14.07pm 02/12/2024 (20 minute delay) ?
IME (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.